U.S. Costco Wholesale, McKesson, Starbucks
Corrects named item code to RCH/US from RCH/EUROPE, the same error was there in a previous version of the U.S. research roundup
Sept 24 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Costco Wholesale, McKesson and Starbucks, on Tuesday.
HIGHLIGHTS
* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880 |
* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform |
* McKesson Corp MCK.N: Baird cuts target price to $531 from $603 |
* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1,077 from $1,175 |
* Starbucks SBUX.O: Jefferies cuts to underperform from hold |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Acuity Brands Inc AYI.N: Wells Fargo raises target price to $289 from $260 |
* Affirm Holdings, Inc. AFRM.O: Barclays raises target price to $54 from $50 |
* Apellis Pharmaceuticals Inc APLS.O: Wells Fargo cuts target price to $43 from $47 |
* Axos Financial Inc AX.N: Wedbush cuts target price to $75 from $80 |
* Banc of California Inc BANC.N: Wedbush raises target price to $18 from $14 |
* Banc of California Inc BANC.N: Wedbush raises to outperform from neutral |
* Bankunited Inc BKU.N: Wedbush raises target price to $40 from $39 |
* Biohaven Ltd BHVN.N: Bernstein raises target price to $66 from $55 |
* Biohaven Ltd BHVN.N: RBC raises target price to $68 from $59 |
* Black Diamond Therapeutics BDTX.O: Piper Sandler raises target price to $15 from $12 |
* Black Diamond Therapeutics Inc BDTX.O: Stifel raises target price to $18 from $15 |
* BP BP.N: Jefferies cuts target price to $40.1 from $43.8 |
* Braze Inc BRZE.O: Canaccord Genuity cuts target price to $45 from $53 |
* Braze Inc BRZE.O: D.A. Davidson cuts target price to $55 from $65 |
* Braze Inc BRZE.O: Oppenheimer cuts target price to $51 from $60 |
* Braze Inc BRZE.O: Oppenheimer cuts target price to $51 from $60 |
* Braze Inc BRZE.O: TD Cowen cuts target price to $45 from $52 |
* Bread Financial Holdings Inc BFH.N: Jefferies cuts target price to $50 from $55 |
* Celsius Holdings Inc CELH.O: Piper Sandler cuts target price to $47 from $50 |
* CF Industries Holdings Inc CF.N: Wells Fargo raises target price to $92 from $88 |
* Charles Schwab SCHW.N: Deutsche Bank cuts target price to $77 from $88 |
* Church & Dwight Co Inc CHD.N: Piper Sandler initiates with overweight rating; PT $120 |
* Church & Dwight Co., Inc. CHD.N: Wells Fargo raises target price to $113 from $108 |
* Cibus Inc CBUS.O: Alliance Global Partners cuts target price to $23.50 from $25 |
* Cogent Biosciences Inc COGT.O: Citigroup raises target price to $15 from $13 |
* Colgate-Palmolive Co CL.N: Piper Sandler initiates with overweight rating; target $121 |
* Columbia Banking System Inc COLB.O: Wedbush raises target price to $31 from $28 |
* Columbia Banking System Inc COLB.O: Wedbush raises to outperform from neutral |
* Comerica Inc CMA.N: Wedbush adds stock to its best ideas list |
* Comerica Inc CMA.N: Wedbush raises target price to $75 from $52 |
* Comerica Inc CMA.N: Wedbush raises to outperform from neutral |
* Compass Inc. COMP.N: Oppenheimer raises target price to $8 from $6 |
* Conagra Brands Inc CAG.N: Jefferies raises target price to $30 from $27 |
* Constellation Brands Inc STZ.N: Barclays raises target price to $309 from $295 |
* Constellation Energy CEG.O: Barclays raises target price to $280 from $211 |
* Constellation Energy Corp CEG.O: BMO raises target price to $278 from $246 |
* Constellation Energy Corp CEG.O: UBS raises target price to $307 from $230 |
* Corbus Pharmaceuticals Holdings Inc CRBP.O: Mizuho cuts target price to $42 from $74 |
* Corning GLW.N: Mizuho raises target price to $51 from $47 |
* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880 |
* Costco Wholesale Corp COST.O: Truist Securities cuts to hold from buy |
* Coty Inc. COTY.N: Wells Fargo cuts target price to $10 from $11 |
* Crowdstrike CRWD.O: Jefferies raises target price to $345 from $315 |
* Cullen/Frost Bankers Inc CFR.N: Wedbush cuts target price to $123 from $124 |
* Customers Bancorp Inc CUBI.N: Wedbush cuts target price to $53 from $79 |
* Customers Bancorp Inc CUBI.N: Wedbush cuts to neutral from outperform |
* CVB Financial Corp CVBF.O: Wedbush cuts target price to $20 from $21 |
* Dayforce Inc DAY.N: Keybanc initiates coverage with overweight rating; target price $70 |
* Doordash DASH.O: Raymond James resumes coverage with outperform rating; target $155 |
* Edgewell Personal Care Company EPC.N: Wells Fargo cuts target price to $41 from $43 |
* EOG Resources Inc EOG.N: JP Morgan raises target price to $139 from $135 |
* Equinix Inc EQIX.O: CFRA cuts to hold from buy |
* Equity Residential EQR.N: BofA Global Research raises price objective to $82 from $78 |
* Essex Property Trust Inc ESS.N: BofA Global Research raises price objective to $321 from $307 |
* Fibrobiologics Inc FBLG.O: Maxim Group initiates coverage with buy rating; target price $12 |
* First Citizens Bancshares FCNCA.O: Wedbush cuts target price to $2150 from $2450 |
* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform |
* First Citizens Bancshares FCNCA.O: Wedbush removes stock from its best ideas list |
* First Horizon Corp FHN.N: Wedbush cuts target price to $17 from $20 |
* First Horizon Corp FHN.N: Wedbush cuts to neutral from outperform |
* First Horizon Corp FHN.N: Wedbush removes stock from its best ideas list |
* Foghorn Therapeutics FHTX.O: Morgan Stanley raises target price to $9.00 from $6.00 |
* Fox Corp FOXA.O: Guggenheim raises target price to $45 from $44 |
* GE Vernova Inc GEV.N: Guggenheim initiates coverage with buy rating; target price $300 |
* Hanmi Financial Corp HAFC.O: Wedbush cuts target price to $21 from $22 |
* Hershey HSY.N: Barclays cuts target price to $202 from $204 |
* Hewlett Packard Enterprise Co HPE.N: Citigroup resumes with neutral rating; target $20 |
* Home Depot Inc HD.N: Oppenheimer raises target price to $400 from $345 |
* Hut 8 Corp HUT.O: Needham raises target price to $16.50 from $15 |
* Ideaya Biosciences Inc IDYA.O: Wedbush cuts target price to $52 from $54 |
* Insperity Inc NSP.N: William Blair cuts to market perform rating |
* Instacart CART.O: Morgan Stanley cuts target price to $41.00 from $45.00 |
* Invitation Homes Inc INVH.N: BofA Global Research cuts price objective to $37 from $39 |
* Juniper Networks Inc JNPR.N: Citigroup resumes coverage with neutral rating; target price $40 |
* Kenvue Inc KVUE.N: Jefferies initiates coverage with buy rating; target price $27 |
* Kenvue Inc KVUE.N: RBC cuts to sector perform from outperform |
* Keurig DR Pepper Inc. KDP.O: Wells Fargo raises target price to $43 from $41 |
* Keycorp KEY.N: Wedbush raises target price to $18 from $17 |
* Kimberly-Clark Corporation KMB.N: Wells Fargo raises target price to $140 from $134 |
* Lamb Weston Holdings Inc LW.N: TD Cowen raises target price to $65 from $61 |
* Lennar Corp LEN.N: Citigroup raises target price to $196 from $164 |
* Leonardo DRS Inc DRS.O: BofA Global Research raises price objective to $30 from $26 |
* Light & Wonder Inc LNW.O: JP Morgan cuts target price to $103 from $111 |
* Lipocine Inc LPCN.O: Alliance Global Partners initiates with buy rating; target $10 |
* Lowe's Companies Inc LOW.N: Oppenheimer raises target price to $305 from $230 |
* Lowe's Companies Inc LOW.N: Oppenheimer raises to outperform from perform |
* Lowe's Cos. LOW.N: Oppenheimer raises target price to $305 from $230 |
* Lowe's Cos. LOW.N: Oppenheimer raises to outperform from perform |
* Lyft Inc LYFT.O: Raymond James resumes coverage with market perform rating |
* M&T Bank Corp MTB.N: Wedbush raises target price to $210 from $208 |
* Maplebear Inc CART.O: Raymond James initiates coverage with market perform rating |
* McKesson Corp MCK.N: Baird cuts target price to $531 from $603 |
* McKesson Corp MCK.N: Baird cuts to neutral |
* Modine Manufacturing Co MOD.N: D.A. Davidson raises target price to $155 from $140 |
* Molson Coors Beverage Company TAP.N: Wells Fargo cuts target price to $52 from $54 |
* Mosaic Co MOS.N: Wells Fargo cuts target price to $27 from $29 |
* National Health Investors NHI.N: BofA Global Research initiates with buy rating |
* National Health Investors NHI.N: BofA Global Research initiates with price objective $92 |
* Newell Brands Inc. NWL.O: Wells Fargo cuts target price to $8 from $9 |
* Okta Inc OKTA.O: Jefferies cuts target price to $85 from $100 |
* P&G PG.N: Piper Sandler initiates coverage with neutral rating; target price $174 |
* Pacific Premier Bancorp Inc PPBI.O: Wedbush cuts target price to $27 from $28 |
* Pacira Biosciences Inc PCRX.O: Jefferies raises target price to $18 from $15 |
* Pfizer PFE.N: Guggenheim raises target price to $36 from $35 |
* Pinterest PINS.N: Oppenheimer initiates coverage With Outperform rating; target $45 |
* Prestige Consumer Healthcare PBH.N: Jefferies assumes with hold vs buy rating; PT $76 vs $70 |
* Procore Technologies PCOR.N: Baird initiates coverage with outperform rating; PT $73 |
* Prosperity Bancshares Inc PB.N: Wedbush raises target price to $90 from $75 |
* Prosperity Bancshares Inc PB.N: Wedbush raises to outperform from neutral |
* Protagonist Therapeutics Inc PTGX.O: TD Cowen initiates coverage with buy rating; PT $65 |
* Public Service Enterprise Group Inc PEG.N: UBS raises target price to $94 from $87 |
* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1077 from $1175 |
* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts to market perform from outperform |
* Regeneron Pharmaceuticals Inc REGN.O: RBC cuts target price to $1,252 from $1,282 |
* Regions Financial RF.N: Wedbush raises target price to $28 from $23 |
* Regions Financial RF.N: Wedbush raises to outperform from neutral |
* Reinsurance Group of America Inc RGA.N: Raymond James raises target to $250 from $228 |
* Replimune Group Inc REPL.O: JP Morgan raises target price to $17 from $14 |
* Ryan Specialty Holdings Inc RYAN.N: BMO raises target price to $75 from $65 |
* Ryan Specialty Holdings Inc RYAN.N: BMO raises to outperform from market perform |
* Sable Offshore Corp SOC.N: Benchmark raises target price to $37 from $24 |
* Salesforce Inc CRM.N: Piper Sandler raises target price to $325 from $268 |
* Salesforce Inc CRM.N: Piper Sandler raises to overweight from neutral |
* Sallie Mae SLM.O: Wedbush cuts target price to $26 from $29 |
* Shake Shack Inc SHAK.N: JP Morgan cuts target price to $102 from $105 |
* Sharkninja Inc SN.N: Canaccord Genuity raises target price to $126 from $105 |
* Sirius XM Holdings Inc SIRI.O: Morgan Stanley resumes with underweight rating; PT $23 |
* Snowflake Inc SNOW.N: UBS cuts target price to $125 from $155 |
* Spectrum Brands Holdings, Inc. SPB.N: Wells Fargo raises target price to $95 from $90 |
* Starbucks SBUX.O: Jefferies cuts target price to $76 from $80 |
* Starbucks SBUX.O: Jefferies cuts to underperform from hold |
* Talen Energy Corp. TLN.O: Oppenheimer raises target price to $210 from $167 |
* Texas Capital Bancshares Inc TCBI.O: Wedbush raises target price to $77 from $70 |
* the Clorox Company CLX.N: Wells Fargo raises target price to $155 from $135 |
* the Estee Lauder Companies Inc. EL.N: Wells Fargo cuts target price to $105 from $117 |
* Tradeweb Markets Inc TW.O: Jefferies raises target price to $118 from $109 |
* Tripadvisor Inc TRIP.O: Citigroup cuts target price to $16 from $20 |
* Triumph Group Inc TGI.N: BofA Global Research cuts to underperform from buy |
* Triumph Group Inc TGI.N: BofA Global Research cuts price objective to $12 from $17 |
* Uber UBER.N: Raymond James resumes coverage with strong buy rating; price target $90 |
* Union Pacific Corp UNP.N: BofA Global Research cuts price objective to $270 from $273 |
* Valley National Bancorp VLY.O: Wedbush raises target price to $10 from $9 |
* Verizon VZ.N: Raymond James raises target price to $48 from $44 |
* Vistra Corp VST.N: Jefferies raises target price to $137 from $99 |
* Walmart WMT.N: Truist Securities raises target price to $89 from $76 |
* Walmart WMT.N: Truist Securities raises to buy from hold |
* Western Alliance Bancorp WAL.N: Wedbush adds stock to its best ideas list |
* Western Alliance Bancorp WAL.N: Wedbush raises target price to $105 from $90 |
* Zevra Therapeutics Inc ZVRA.O: Canaccord Genuity raises target price to $25 from $22 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.